Scottish Enterprise's Biotechnology Portfolio

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.

ŌGI Bio is a Biotechnology Research company.

Roslin Technologies is a biotechnology company that focuses on developing technologies for the agricultural and animal health sectors.

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.

Green Bioactives is a sustainable, plant cell-based biomanufacturing platform for plant biomolecules, utilising natural plant biochemistry.

Northern Light Microscopy creates optical solutions for biological issues.

Wobble Genomics specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

Lentitek is a cell and gene therapy company.

Bioliberty are a medtech start-up developing rehabilitation solutions for degenerative and traumatic conditions.

TileBio is an AI-driven biotech startup focused on pathology foundation models.

uFraction8 develops microfluidics-based filtration systems to help bio-manufacturers to harvest biomass sustainably and more efficiently.

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

Dyneval is a biotechnology start-up.

Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.

Invizius provides dialysis treatments and other extra-corporeal treatments for patients.

MiAlgae is a new-age microalgal production company .

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

Glen Clova Scientific is a company that developing a new gneration of active biological drugs.

Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.

Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.

Beta Bugs is an insect genetics company that develops and distributes high-performance Black Soldier Fly breeds to insect farmers.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours for cancer research

Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.

Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .

Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.

Macomics is an immuno-oncology company.

Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.

Rhizocore Technologies produces locally-adapted mycorrhizal fungi to enhance tree planting success.

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

Clear Surgical is an innovative product that is set to transform surgical theatres.

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations.

Regenerating orthopedic and dental implant design to help patients heal faster with far less pain.

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.

TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.